Blue banner that says "Press Release"

Historic Veterans’ Prostate Cancer Bill Passes Unopposed in the House


Media Contact: 
Ilana Ostrin

Capitol Building

WASHINGTON, D.C. –  The House unanimously passed H.R. 6092, the “Veteran’s Prostate Cancer Treatment and Research Act,” designed to establish a national clinical pathway for prostate cancer. This standardized system of care would enhance treatment and increase access to clinical trials via a registry for the most commonly diagnosed cancer in the Veterans Health Administration.

“Our service members have dedicated their lives to the American people and they deserve to receive the same high quality care any one of us would expect when faced with a diagnosis of prostate cancer,” said Alison Manson, ZERO’s Vice President of Advocacy and Government Relations. “ZERO applauds the House of Representatives for its efforts to ensure that the nearly half a million veterans facing prostate cancer are no longer subjected to the risks of an unorganized health system.”  

Congressman Neal Dunn, M.D. (FL-02), a former urologist, sponsored this effort. No timetable has been set for when the Senate may vote on the measure, but it’s expected to move quickly through the Senate.

Veterans face prostate cancer at rates that double those of civilians. For more information on ZERO’s work with veterans, visit

About ZERO Prostate Cancer

ZERO Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of our community. From early detection to survivorship, ZERO is the premier resource for prostate cancer patients and their families to access comprehensive support, make meaningful connections, and take action to save lives. Our dedicated national and chapter staff is joined with a growing team of passionate volunteer champions to increase advocacy, awareness, and community engagement to ZERO out prostate cancer. ZERO is recognized with four out of four stars by Charity Navigator and accredited by the Better Business Bureau. ZERO spends more on programs than any other prostate cancer charity, dedicating 85 cents of every dollar to support, education, and research.